|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.1935 SEK | -1.78% |
|
-7.86% | +7.80% |
| 08-25 | XP Chemistries AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-25 | XP Chemistries Q2 Net Sales Amounted To SEK 59,000 | RE |
| Market Cap | 60.75M 6.27M 5.41M 5.12M 4.63M 8.7M 599M 8.75M 23.37M 305M 23.56M 23.04M 971M | P/E 2024 |
-1.48x | P/E 2025 | -5.22x |
|---|---|---|---|---|---|
| Enterprise Value | 45.53M 4.7M 4.05M 3.84M 3.47M 6.52M 449M 6.56M 17.51M 228M 17.66M 17.27M 728M | EV / Sales 2024 |
43.7x | EV / Sales 2025 | 126x |
| Free-Float |
44.34% | Yield 2024 * |
-
| Yield 2025 | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| XPC | Delayed | |
Deutsche Boerse AG
| 86Q | Delayed | |
|
Börse Stuttgart
| 86Q | Delayed | |
|
Boerse Muenchen
| 86Q | Real-time |
| 1 day | -1.78% | ||
| 1 week | -7.86% | ||
| Current month | +9.32% | ||
| 1 month | +13.82% | ||
| 3 months | +12.50% | ||
| 6 months | +4.31% | ||
| Current year | +7.80% |
| 1 week | 0.19 |  | 0.22 |
| 1 month | 0.16 | | 0.22 |
| Current year | 0.15 | | 0.22 |
| 1 year | 0.15 | | 0.29 |
| 3 years | 0.03 | | 0.5 |
| 5 years | 0.03 | | 4.5 |
| 10 years | 0.03 | | 4.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Nelsson
CEO | Chief Executive Officer | 43 | 2020-12-31 |
Anders Frejdh
DFI | Director of Finance/CFO | 52 | 2020-12-31 |
Shuang Zheng Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Armando Córdova
CHM | Chairman | 56 | 2014-12-31 |
Samson Afewerki
BRD | Director/Board Member | 41 | 2014-12-31 |
Anna Svantes
BRD | Director/Board Member | 35 | 2020-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/15/24 | Buy | Chief Executive Officer | 20,000 | 0.0136% | ||
| 4/15/24 | Buy | Chief Executive Officer | 30,000 | 0.0204% | ||
| 4/15/24 | Buy | Chief Executive Officer | 50,000 | 0.0340% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.78% | -7.86% | -33.28% | -52.34% | 6.27M | |
| -0.65% | -2.93% | +47.52% | +87.34% | 994B | |
| -0.29% | -3.51% | +48.78% | +63.27% | 640B | |
| +0.83% | +0.26% | +16.76% | +72.52% | 454B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 337B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 261B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 246B | |
| -1.34% | -13.70% | +33.47% | +44.18% | 204B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 190B | |
| -0.75% | -4.82% | +21.94% | +86.55% | 178B | |
| Average | -0.83% | -5.97% | +15.14% | +31.59% | 350.48B | |
| Weighted average by Cap. | -0.51% | -4.42% | +29.87% | +55.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 284K 29.32K 25.27K 23.93K 21.64K 40.68K 2.8M 40.9K 109K 1.42M 110K 108K 4.54M | 327K 33.81K 29.14K 27.6K 24.96K 46.91K 3.23M 47.16K 126K 1.64M 127K 124K 5.23M |
| Net income | -7.13M -737K -635K -601K -544K -1.02M -70.37M -1.03M -2.74M -35.76M -2.77M -2.71M -114M | -8.52M -880K -758K -718K -650K -1.22M -84.06M -1.23M -3.28M -42.71M -3.3M -3.23M -136M |
| Net Debt | -2.15M -222K -191K -181K -164K -307K -21.16M -309K -825K -10.75M -832K -814K -34.28M | -15.23M -1.57M -1.36M -1.28M -1.16M -2.18M -150M -2.19M -5.86M -76.33M -5.9M -5.77M -243M |
Employees
3
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | SEK 0.1935 | -1.78% | 155,277 |
| 26-09-10 | SEK 0.1970 | -2.96% | 320,340 |
| 26-09-09 | SEK 0.2030 | +0.50% | 344,585 |
| 26-09-08 | SEK 0.2020 | -0.98% | 285,314 |
| 26-09-07 | SEK 0.2040 | -2.86% | 826,598 |
- Stock Market
- Stocks
- XPC Stock
Select your edition
All financial news and data tailored to specific country editions
